PowerTOST: CVfromCI [Study As­sess­ment]

posted by Rosy – Mexico, 2019-02-20 15:25 (649 d 17:45 ago) – Posting: # 19939
Views: 6,401

(edited by Rosy on 2019-02-20 15:37)

»              Not interested in other members’ opinions?

I'm sorry if I looked rude, I was just trying to follow the thread of the publication ... of course, I'm interested in any opinion. My deepest apologies to everyone.

» Parallel‽

I had a miscomprehension of the statistical analysis, i read again and they used an ANOVA included the following factors: sequence (SEQ), subject nested within sequence (SUBJECT [SEQ]), period (PHASE), and treatment (TREAT). I though that they maked a paired comparation, one at time.

But in this case: https://accp1.onlinelibrary.wiley.com/doi/abs/10.1177/009127009903901108?sid=nlm%3Apubmed

The study had an open-label, single-dose, three-way crossover design. Subjects were randomly assigned to receive one of three treatments per period

Design: 3x2 N= 17

A vs B ----> IC (84.9-106)
A vs C ----> IC (169-211)
B vs C ----> IC (178-222)

How to calculate %CV Intra-individual???

100*CVfromCI(lower=0.849, upper=1.06, n=17, design='2x2x3', alpha=0.05)

it's that correct???

Complete thread:

 Admin contact
21,224 posts in 4,427 threads, 1,481 registered users;
online 12 (1 registered, 11 guests [including 2 identified bots]).
Forum time: Tuesday 09:11 CET (Europe/Vienna)

The fundamental cause of trouble in the world today is
that the stupid are cocksure
while the intelligent are full of doubt.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz